1Hayashi K,Morishita R,Nakagami H,et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons[J]. Gene Ther, 2001;8(15):1167
2Tomita N,Morishita R,Higaki J,et al. Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor[J]. J Atheroscler Thromb, 2000;7(1):1
3Morishita R.Adventure of gene therapy into the brain: A new era for cardiovascular gene therapy[J]. Circ Res, 2000;87(9):719
4Manno EM,Gress DR ,Ogilvy CS,et al .the safety and efficacy of cyclosporine A in the prevention of vasospasm in patient with Fisher Grade 3 subarachnoid hemorrhages:A pilot study[J]. Neurosurgery, 1997;40:289
5Toyada K,Faraci FM,Watanabe Y,et al. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage[J]. Circ Res,2000;87(9):818
6Weihl C, Macdonald RL, Stoodley M, Luders J, Lin G. Gene therapy for cerebrovascular disease[J]. Neurosurgery, 1999;44(2):239
8Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease[J]. J Mol Cell Cardiol, 2001;33(3):379
9Gunnett CA,Heistad DD. The future of gene therapy for stroke[J].Curr Hypertens Rep, 2001;3(1):36
10Lawrence MS, Ho DY, Sun GH,et al .overexpressin of bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo[J]. J Neurosci,1996;16:486
